Emirates Telecommunications Group Company PJSC (ADX:EAND)

Ligand Pharmaceuticals Income Statement

Financials in millions AED. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	65,807	59,203	53,752	52,434	53,342	51,708
Revenue Growth (YoY)	18.70%	10.14%	2.51%	-1.70%	3.16%	-0.92%
Cost of Revenue	43,310	38,159	36,598	38,053	38,493	36,510
Gross Profit	22,497	21,044	17,154	14,381	14,849	15,198
Selling, General & Admin	1,321	1,321	1,066	1,040	1,130	924.02
Operating Expenses	2,220	2,111	1,872	1,798	2,036	1,965
Operating Income	20,277	18,933	15,283	12,583	12,813	13,233
Interest Expense	-2,774	-3,939	-3,146	-1,992	-1,195	-1,202
Interest & Investment Income	2,211	2,211	3,391	1,704	550.77	648.79
Earnings From Equity Investments	2,191	2,475	761.04	417.36	297.46	197.41
Currency Exchange Gain (Loss)	11.75	11.75	5.65	-43.19	-21.48	16.59
Other Non Operating Income (Expenses)	5,064	-761.33	-479.42	-343.83	393.31	-765.51
EBT Excluding Unusual Items	26,981	18,932	15,815	12,325	12,838	12,128
Impairment of Goodwill	-1,275	-1,275	-	-	-34.65	-148.16
Gain (Loss) on Sale of Investments	-54.43	-54.43	1.81	-44.39	114.51	-65.02
Asset Writedown	-20.86	-20.29	-80.9	-2.76	-113.49	-148.55
Pretax Income	25,631	17,582	15,735	12,278	12,804	11,766
Income Tax Expense	10,307	6,999	4,591	1,752	1,745	1,451
Earnings From Continuing Operations	15,324	10,583	11,144	10,526	11,059	10,316
Net Income to Company	15,324	10,583	11,144	10,526	11,059	10,316
Minority Interest in Earnings	-1,239	169.14	-839.66	-518.34	-1,742	-1,289
Net Income	14,085	10,752	10,305	10,007	9,317	9,027
Net Income to Common	14,085	10,752	10,305	10,007	9,317	9,027
Net Income Growth	27.01%	4.35%	2.97%	7.41%	3.22%	3.84%
Shares Outstanding (Basic)	8,706	8,697	8,697	8,697	8,697	8,697
Shares Outstanding (Diluted)	8,706	8,697	8,697	8,697	8,697	8,697
EPS (Basic)	1.62	1.24	1.18	1.15	1.07	1.04
EPS (Diluted)	1.62	1.24	1.18	1.15	1.07	1.04
EPS Growth	27.06%	4.35%	2.97%	7.41%	3.22%	3.84%
Free Cash Flow	17,168	15,025	9,166	12,387	11,665	12,895
Free Cash Flow Per Share	1.97	1.73	1.05	1.42	1.34	1.48
Dividend Per Share	0.830	0.830	0.800	0.800	0.800	0.800
Dividend Growth	107.50%	3.75%	-	-	-	-
Gross Margin	34.19%	35.55%	31.91%	27.43%	27.84%	29.39%
Operating Margin	30.81%	31.98%	28.43%	24.00%	24.02%	25.59%
Profit Margin	21.40%	18.16%	19.17%	19.09%	17.47%	17.46%
Free Cash Flow Margin	26.09%	25.38%	17.05%	23.62%	21.87%	24.94%
EBITDA	28,392	25,671	22,575	19,668	20,430	20,636
EBITDA Margin	43.14%	43.36%	42.00%	37.51%	38.30%	39.91%
D&A For EBITDA	8,115	6,738	7,292	7,085	7,617	7,404
EBIT	20,277	18,933	15,283	12,583	12,813	13,233
EBIT Margin	30.81%	31.98%	28.43%	24.00%	24.02%	25.59%
Effective Tax Rate	40.21%	39.81%	29.18%	14.27%	13.63%	12.33%

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.